BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

438 related articles for article (PubMed ID: 17804506)

  • 1. Myc and human papillomavirus type 16 E7 genes cooperate to immortalize human keratinocytes.
    Liu X; Disbrow GL; Yuan H; Tomaic V; Schlegel R
    J Virol; 2007 Nov; 81(22):12689-95. PubMed ID: 17804506
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cell-restricted immortalization by human papillomavirus correlates with telomerase activation and engagement of the hTERT promoter by Myc.
    Liu X; Dakic A; Chen R; Disbrow GL; Zhang Y; Dai Y; Schlegel R
    J Virol; 2008 Dec; 82(23):11568-76. PubMed ID: 18818322
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Telomerase activation by human papillomavirus type 16 E6 protein: induction of human telomerase reverse transcriptase expression through Myc and GC-rich Sp1 binding sites.
    Oh ST; Kyo S; Laimins LA
    J Virol; 2001 Jun; 75(12):5559-66. PubMed ID: 11356963
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Degradation of p53, not telomerase activation, by E6 is required for bypass of crisis and immortalization by human papillomavirus type 16 E6/E7.
    McMurray HR; McCance DJ
    J Virol; 2004 Jun; 78(11):5698-706. PubMed ID: 15140967
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transcriptional activation of the telomerase hTERT gene by human papillomavirus type 16 E6 oncoprotein.
    Veldman T; Horikawa I; Barrett JC; Schlegel R
    J Virol; 2001 May; 75(9):4467-72. PubMed ID: 11287602
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Papillomavirus type 16 E6/E7 and human telomerase reverse transcriptase in esophageal cell immortalization and early transformation.
    Zhang H; Jin Y; Chen X; Jin C; Law S; Tsao SW; Kwong YL
    Cancer Lett; 2007 Jan; 245(1-2):184-94. PubMed ID: 16488074
    [TBL] [Abstract][Full Text] [Related]  

  • 7. HPV-16 E7 protein bypasses keratinocyte growth inhibition by serum and calcium.
    Pei XF; Sherman L; Sun YH; Schlegel R
    Carcinogenesis; 1998 Aug; 19(8):1481-6. PubMed ID: 9744546
    [TBL] [Abstract][Full Text] [Related]  

  • 8. HPV E7 contributes to the telomerase activity of immortalized and tumorigenic cells and augments E6-induced hTERT promoter function.
    Liu X; Roberts J; Dakic A; Zhang Y; Schlegel R
    Virology; 2008 Jun; 375(2):611-23. PubMed ID: 18367227
    [TBL] [Abstract][Full Text] [Related]  

  • 9. HPV16 E7 protein and hTERT proteins defective for telomere maintenance cooperate to immortalize human keratinocytes.
    Miller J; Dakic A; Chen R; Palechor-Ceron N; Dai Y; Kallakury B; Schlegel R; Liu X
    PLoS Pathog; 2013; 9(4):e1003284. PubMed ID: 23592995
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The E7 protein of the cottontail rabbit papillomavirus immortalizes normal rabbit keratinocytes and reduces pRb levels, while E6 cooperates in immortalization but neither degrades p53 nor binds E6AP.
    Ganzenmueller T; Matthaei M; Muench P; Scheible M; Iftner A; Hiller T; Leiprecht N; Probst S; Stubenrauch F; Iftner T
    Virology; 2008 Mar; 372(2):313-24. PubMed ID: 18067942
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bmi-1 cooperates with human papillomavirus type 16 E6 to immortalize normal human oral keratinocytes.
    Kim RH; Kang MK; Shin KH; Oo ZM; Han T; Baluda MA; Park NH
    Exp Cell Res; 2007 Feb; 313(3):462-72. PubMed ID: 17161394
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cytoplasmic poly(A) binding proteins regulate telomerase activity and cell growth in human papillomavirus type 16 E6-expressing keratinocytes.
    Katzenellenbogen RA; Vliet-Gregg P; Xu M; Galloway DA
    J Virol; 2010 Dec; 84(24):12934-44. PubMed ID: 20943973
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differential in vitro immortalization capacity of eleven (probable) [corrected] high-risk human papillomavirus types.
    Schütze DM; Snijders PJ; Bosch L; Kramer D; Meijer CJ; Steenbergen RD
    J Virol; 2014 Feb; 88(3):1714-24. PubMed ID: 24257607
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Human papillomavirus type 16 E6 and E7 proteins inhibit differentiation-dependent expression of transforming growth factor-beta2 in cervical keratinocytes.
    Nees M; Geoghegan JM; Munson P; Prabhu V; Liu Y; Androphy E; Woodworth CD
    Cancer Res; 2000 Aug; 60(15):4289-98. PubMed ID: 10945644
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Human papillomavirus type 16 E6 and E7 cooperate to increase epidermal growth factor receptor (EGFR) mRNA levels, overcoming mechanisms by which excessive EGFR signaling shortens the life span of normal human keratinocytes.
    Akerman GS; Tolleson WH; Brown KL; Zyzak LL; Mourateva E; Engin TS; Basaraba A; Coker AL; Creek KE; Pirisi L
    Cancer Res; 2001 May; 61(9):3837-43. PubMed ID: 11325860
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mutant p53 can substitute for human papillomavirus type 16 E6 in immortalization of human keratinocytes but does not have E6-associated trans-activation or transforming activity.
    Sedman SA; Hubbert NL; Vass WC; Lowy DR; Schiller JT
    J Virol; 1992 Jul; 66(7):4201-8. PubMed ID: 1318401
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The human papillomavirus E6/E7 genes induce discordant changes in the expression of cell growth regulatory proteins.
    Pei XF
    Carcinogenesis; 1996 Jul; 17(7):1395-401. PubMed ID: 8706240
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Human papillomavirus E6 and Myc proteins associate in vivo and bind to and cooperatively activate the telomerase reverse transcriptase promoter.
    Veldman T; Liu X; Yuan H; Schlegel R
    Proc Natl Acad Sci U S A; 2003 Jul; 100(14):8211-6. PubMed ID: 12821782
    [TBL] [Abstract][Full Text] [Related]  

  • 19. E box-dependent activation of telomerase by human papillomavirus type 16 E6 does not require induction of c-myc.
    Gewin L; Galloway DA
    J Virol; 2001 Aug; 75(15):7198-201. PubMed ID: 11435602
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Establishment of immortalized human hepatocytes by introduction of HPV16 E6/E7 and hTERT as cell sources for liver cell-based therapy.
    Tsuruga Y; Kiyono T; Matsushita M; Takahashi T; Kasai H; Matsumoto S; Todo S
    Cell Transplant; 2008; 17(9):1083-94. PubMed ID: 19177844
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.